Authors:
Rosenberg, E
Demopoulos, RI
Zeleniuch-Jacquotte, A
Yee, H
Sorich, J
Speyer, JL
Newcomb, EW
Citation: E. Rosenberg et al., Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival, HUMAN PATH, 32(8), 2001, pp. 808-813
Authors:
Hochster, H
Speyer, JL
Mandeli, JP
Runowicz, C
Wadler, S
Berk, G
Wallach, R
Holland, JF
Citation: H. Hochster et al., A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer, GYNECOL ONC, 72(3), 1999, pp. 292-297
Citation: Dp. Malladi et Jl. Speyer, A generalized Shiryayev sequential probability ratio test for change detection and isolation, IEEE AUTO C, 44(8), 1999, pp. 1522-1534
Authors:
Newcomb, EW
Sosnow, M
Demopoulos, RI
Zeleniuch-Jacquotte, A
Sorich, J
Speyer, JL
Citation: Ew. Newcomb et al., Expression of the cell cycle inhibitor p27(KIP1) is a new prognostic marker associated with survival in epithelial ovarian tumors, AM J PATH, 154(1), 1999, pp. 119-125